Skip to content
Screener

Ambarella AMBA Accretion (Amortization) of Discounts and Premiums, Investments

Accretion (Amortization) of Discounts and Premiums, Investments at other companies

Golub Capital logo
Golub CapitalGBDC
$3.22M+52.7%
Ambarella logo
AmbarellaAMBA
$7K-90.0%
IDEAYA Biosciences, Inc. logo
IDEAYA Biosciences, Inc.IDYA
$1.21M-67.9%
Enliven Therapeutics logo
Enliven TherapeuticsELVN
-$266K-691%
C3.ai logo
C3.aiAI
$1.83M-41.1%
Jade Biosciences logo
Jade BiosciencesJBIO
$493K

Other financials

Income statement

See full
Revenue$100.4M+16.9%
Gross profit$58.6M+13.7%
Operating income-$19.4M+24.9%
Net income-$18.1M+25.6%
EPS (diluted)-$0.41+29.3%

Balance sheet

See full
Cash & equivalents$114.4M-19.0%
Total debt$13.3M+202%
Total equity$605.8M+5.8%
Total assets$794.8M+13.2%

Cash flow

See full
Operating cash flow-$25.6M-273%
CapEx$4.0M-13.3%
Free cash flow-$29.6M-389%

Valuation

See full
Market cap$3.81B+39.5%
Enterprise value$3.71B+43.1%
P/S9.4×+1.6×

Profitability

See full
Gross margin58.8%-1.5pp
Operating margin-18.8%-6.0pp
Net margin-17.2%-5.5pp
FCF margin4.5%-11.2pp

Returns & leverage

See full
Return on equity-11.8%-3.1pp
Debt / equity0.0×
Current ratio2.4×-0.3×

Where this comes from

Reported directly by Ambarella in its filing.

Tagged under the XBRL concept us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments.

The source filing: Ambarella’s 10-Q, filed June 2, 2026.

Filed
Jun 2, 2026, 2:40 PM EDT
Fiscal quarter
Q1 FY2027
Calendar quarter
Q2 2026
Accession
0001193125-26-253198
Line itemThree Months Ended April 30, 2026Three Months Ended April 30, 2025
Net loss$(18,093)$(24,328)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Depreciation and amortization6,3676,748
Amortization (accretion) of premium (discount) on marketable debt securities, net(7)(70)
Stock-based compensation21,89326,130
Deferred income taxes326
Other non-cash items, net(195)(239)
Changes in operating assets and liabilities:

ITEM 1. Financial Statements

FAQ

What is Ambarella's accretion (amortization) of discounts and premiums, investments?
Ambarella (AMBA) reported accretion (amortization) of discounts and premiums, investments of $7K in Q1 2026.
How has Ambarella's accretion (amortization) of discounts and premiums, investments changed year-over-year?
Ambarella's accretion (amortization) of discounts and premiums, investments decreased by 90.0% year-over-year, from $70K to $7K.
What is the long-term trend for Ambarella's accretion (amortization) of discounts and premiums, investments?
Over 4 years (2022 to 2026), Ambarella's accretion (amortization) of discounts and premiums, investments has grown at a -36.8% compound annual growth rate (CAGR), from -$1.03M to $165K.
What does accretion (amortization) of discounts and premiums, investments mean?
This metric represents the non-cash adjustments to the carrying value of investment securities resulting from the amortization of premiums or the accretion of discounts. It reflects the periodic adjustment of investment income to account for the difference between the purchase price and the maturity value of debt instruments. Investors use this to understand the non-cash impact of investment portfolio management on reported operating cash flows.

Ask your AI about Ambarella's accretion (amortization) of discounts and premiums, investments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude